You just read:

Tanabe Research Labs Announce FDA Acceptance of its IND Application for TR1801-ADC (MT-8633), an ADC Targeting cMet Positive Solid Tumors

News provided by

Tanabe Research Laboratories U.S.A. Inc.

Feb 14, 2019, 09:00 ET